USFDA approval granted for Pregabalin capsule: Strides Pharma

This USFDA approval is a testament to Strides Pharma's dedication to maintaining the highest standards in drug manufacturing.

74
USFDA Drug product Approval
USFDA Approval

USFDA approval

In a noteworthy development, Strides Pharma Science witnessed a surge in its share price as it announced the receipt of USFDA approval from the United States Food and Drug Administration (USFDA) to sell a generic drug for nerve pain.

This USFDA approval, granted to Strides Pharma Global Pte Limited, Singapore, marks a significant milestone for the pharmaceutical company.

USFDA Approval for Pregabalin Capsules

The USFDA approval for Pregabalin capsules, spanning various strengths, underscores Strides Pharma’s commitment to delivering high-quality and therapeutically equivalent medications.

The subsidiary, Strides Pharma Global Pte Limited, Singapore, played a pivotal role in securing this USFDA approval, positioning the company as a key player in the global pharmaceutical landscape.

Pregabalin Capsules Specifications

The approved Pregabalin capsules, ranging from 25 mg to 300 mg, are not only bioequivalent but also therapeutically equivalent to the Reference Listed Drug (RLD), Lyrica capsules of Upjohn US.

This bioequivalence ensures that the generic drug maintains the same efficacy and safety profile as the original medication, providing reassurance to healthcare professionals and patients.

Comparison with Reference Listed Drug (RLD)

Being bioequivalent and therapeutically equivalent to the RLD holds immense importance in the pharmaceutical realm.

It signifies that the generic medication, in this case, Pregabalin capsules, delivers the same therapeutic effect as the branded Lyrica capsules.

This USFDA approval is a testament to Strides Pharma’s dedication to maintaining the highest standards in drug manufacturing.

Medical Applications of Pregabalin Capsules

Pregabalin capsules find application in the treatment of fibromyalgia, a condition characterized by widespread musculoskeletal pain.

The approval of these capsules offers new hope to individuals suffering from fibromyalgia, providing them with an alternative and more accessible treatment option.

Global Expansion Strategies

Strides Pharma’s success in gaining approval from a stringent regulatory authority like the USFDA aligns with its global expansion strategies.

This achievement not only solidifies the company’s presence in the United States but also enhances its credibility on the global stage, attracting potential partnerships and collaborations.

Understanding Fibromyalgia

Fibromyalgia, a chronic disorder characterized by widespread pain, fatigue, and sleep disturbances, poses significant challenges for those affected.

Pregabalin capsules, with their approval for treating fibromyalgia, offer a ray of hope for individuals battling this condition, providing a targeted and effective therapeutic option.

Importance of Generic Drugs

The approval of generic drugs plays a vital role in the pharmaceutical industry.

It not only promotes healthy competition but also contributes to making medications more affordable and accessible to a larger population.

Generic drugs, like Pregabalin capsules, offer comparable efficacy to their branded counterparts, ensuring quality healthcare for all.

Patient Accessibility and Affordability

The approval of generic drugs enhances patient accessibility and affordability.

By offering cost-effective alternatives, pharmaceutical companies contribute to healthcare systems’ sustainability, ensuring that essential medications are within reach for a broader segment of the population.

Investor Implications

Investors are likely to view this USFDA approval as a positive signal for Strides Pharma.

The potential increase in market share and revenue can make the company an attractive prospect for those looking to invest in the pharmaceutical sector. The ripple effect of this news may extend to the broader economic landscape.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news